TRIP12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.032600E-01
Normal-vs-Stage2
7.201200E-01
Normal-vs-Stage3
1.004160E-01
Normal-vs-Stage4
5.371000E-01
Stage1-vs-Stage2
4.035800E-01
Stage1-vs-Stage3
3.307000E-01
Stage1-vs-Stage4
7.183800E-02
Stage2-vs-Stage3
1.382360E-01
Stage2-vs-Stage4
2.331400E-01
Stage3-vs-Stage4
2.484000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.719000E-01
Normal-vs-AfricanAmerican
8.310400E-01
Normal-vs-Asian
7.647000E-01
Caucasian-vs-AfricanAmerican
2.242600E-01
Caucasian-vs-Asian
7.483000E-01
AfricanAmerican-vs-Asian
5.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.914400E-01
Normal-vs-Female
6.830200E-01
Male-vs-Female
7.846400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.264200E-01
Normal-vs-Age(41-60Yrs)
9.025400E-01
Normal-vs-Age(61-80Yrs)
4.221800E-01
Normal-vs-Age(81-100Yrs)
1.990790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.201600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.491600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.879200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.057200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.682100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.900600E-01
Normal-vs-Daily Drinker
1.090790E-01
Normal-vs-Weekly Drinker
5.918000E-01
Normal-vs-Occasional Drinker
9.932000E-01
Normal-vs-Social Drinker
7.940600E-01
Non Drinker-vs-Daily Drinker
2.406400E-01
Non Drinker-vs-Weekly Drinker
8.176400E-01
Non Drinker-vs-Occasional Drinker
2.494000E-01
Non Drinker-vs-Social Drinker
5.478400E-01
Daily Drinker-vs-Weekly Drinker
1.368030E-01
Daily Drinker-vs-Occasional Drinker
7.835700E-03
Daily Drinker-vs-Social Drinker
6.365500E-02
Weekly Drinker-vs-Occasional Drinker
3.544000E-01
Weekly Drinker-vs-Social Drinker
7.056600E-01
Occasional Drinker-vs-Social Drinker
6.305400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.591410E-01
Normal-vs-Grade 2
1.971790E-02
Normal-vs-Grade 3
2.961900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.594100E-02
Grade 1-vs-Grade 3
7.658000E-03
Grade 1-vs-Grade 4
1.591410E-01
Grade 2-vs-Grade 3
1.626420E-01
Grade 2-vs-Grade 4
1.971790E-02
Grade 3-vs-Grade 4
2.961900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.207200E-01
Normal-vs-NonDiabetic
5.578000E-01
Diabetic-vs-NonDiabetic
5.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.303600E-01
Normal-vs-NoPancreatitis
5.653600E-01
Pancreatitis-vs-NoPancreatitis
9.552600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.592600E-01
Normal-vs-N1
7.259200E-01
N0-vs-N1
2.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.277600E-01
Normal-vs-TP53-NonMutant
5.446600E-01
TP53-Mutant-vs-TP53-NonMutant
1.948040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
